Nearly 600 party-goers streamed into the JW Marriott Marquis Miami and Hotel Beaux Arts in downtown Miami for the 20th Anniversary Gala Celebration of UHealth’s Sylvester Comprehensive Cancer Center on Saturday evening, December 8. The spectacular party raised a record total of more than $1.3 million for research and care at Sylvester.
New research identifying a gene responsible for a rare and tough-to-cure subtype of childhood leukemia is laying the groundwork for clinical and treatment advances. Stephen D. Nimer, M.D., Director of Sylvester Comprehensive Cancer Center, was co-author of the study published November 13 in the journal Cancer Cell.
As scores of participants in the Dolphins Cycling Challenge formed the shape of a bicycle on the field of Sun Life Stadium, the Miami Dolphins presented a check for $2.2 million from the event to the Sylvester Comprehensive Cancer Center before Sunday’s game against the Seattle Seahawks.
Miller School Dean Pascal J. Goldschmidt, M.D., and UM Trustee Stuart A. Miller cross the finish line of the third annual Dolphins Cycling Challenge at Sun Life Stadium on Sunday, Nov. 4. They joined 1,500 riders in Miami-Dade, Broward and Palm Beach counties for the two-day ride “tackling cancer one mile at a time.”
Sylvester Comprehensive Cancer Center at Deerfield Beach has received a $20,000 grant from Angie’s Spa Cancer Foundation to provide integrative medicine services to patients undergoing chemotherapy and radiation.
Krishna Komanduri, M.D., the director of the Adult Stem Cell Transplant Program, and his multidisciplinary team at Sylvester Comprehensive Cancer Center performed their 100th stem cell transplant on October 26 -- a historic milestone that underscores the cancer center’s growing prominence.
Long known to stimulate cell growth, the signaling protein Akt has been implicated in a number of human cancers. But in a new study published October 23 in the prestigious journal Science Signaling, a team of researchers led by Stephen D. Nimer, M.D., Director of the Sylvester Comprehensive Cancer Center, found that Akt also can impair the growth of blood-forming stem cells that can develop into cancers like leukemia.
Sylvester Comprehensive Cancer Center will host the first water stop for the third annual Dolphins Cycling Challenge on Saturday, November 3, and needs your support and enthusiasm in welcoming riders who are raising money for cancer research at Sylvester.
Jonathan Trent, M.D., Ph.D., professor of medicine, has been recognized with an Outstanding Care Award by the Sarcoma Alliance and the grateful patient who nominated him.
Steven B. Newman, M.D., a hematologist/oncologist with more than 30 years of clinical, operational and administrative experience, has been appointed executive director for clinical affairs at Sylvester Comprehensive Cancer Center and director of clinical services for the Division of Hematology/Oncology in the Miller School’s Department of Medicine.
J. William Harbour, M.D., a pioneering ocular oncologist and retinal surgeon whose genetic discoveries are transforming the diagnosis and treatment of the most common eye cancer, has joined the Miller School faculty as Vice Chairman for Translational Research at Bascom Palmer Eye Institute and director of its Ocular Oncology Service.
Stephen D. Nimer, M.D., director of the Sylvester Comprehensive Cancer Center, was the keynote speaker at the Greater Miami Chamber of Commerce monthly trustee luncheon, August 1 at Jungle Island.
Sylvester has been recognized as a Center of Excellence by the Myelodysplastic Syndromes Foundation for its research, diagnosis and treatment of myelodysplastic syndromes.
Dipen J. Parekh, M.D., among the world’s most experienced robotic surgeons for urologic oncology, has been named chairman of the Miller School’s Department of Urology.
For the ninth consecutive year, the University of Miami Miller School of Medicine’s Bascom Palmer Eye Institute is the nation’s No. 1 ophthalmology program in U.S. News & World Report’s annual Best Hospitals rankings.
In a ceremony showcasing the colorful handprints of childhood cancer survivors, Hyundai Hope On Wheels and representatives from 10 local Hyundai dealerships awarded the Miller School of Medicine a $75,000 Hyundai Scholar Grant for Dima Hamideh, M.D., chief fellow of pediatric hematology-oncology.
Sara J. Czaja, Ph.D., Leonard M. Miller Professor of Psychiatry and Behavioral Sciences and scientific director of the Center on Aging, will present a special lecture, “Aging Gracefully,” on Thursday, July 26, as part of the Collegetown initiative to enrich the local community with intellectual discourse and presentations by faculty experts.
Creating a new paradigm for treating children with cancer, alex’s place is now open at Sylvester Comprehensive Cancer Center. The first facility of its kind in the nation and the first pediatric oncology clinic at Sylvester, alex’s place merges research and clinical care from an academic medical center with innovative technology designed to ease the anxiety of therapeutic visits.
Trustees, donors, faculty, staff and UM and Miller School leadership celebrated and dedicated the Fred Havenick Intensive Care Unit at Sylvester Comprehensive Cancer Center on May 8.
Fueled by the work of more than 21,000 volunteers, The Pap Corps: Champions for Cancer Research, presented its annual gift to the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine -- a check in the amount of $3.2 million.
One day soon, the 50,000 Americans destined to be diagnosed with head and neck cancer annually could learn with a simple test that they could develop the deadly disease long before the first lesion appears in their mouth. If so, the breakthrough will have been enabled by the research of a Miller School otolaryngologist, the passions of a Georgia attorney and the office that united them.
Stephen D. Nimer, M.D., the new director of the Sylvester Comprehensive Cancer Center, officially starts work this week.
A new analysis by a team of researchers at the Miller School’s Sylvester Comprehensive Cancer Center has found that Hispanic lung cancer patients seem to live longer than white or black patients.
Howard Lessner, M.D., who became the first director of the University of Miami’s Comprehensive Cancer Center in 1972, passed away on April 18 at South Miami Hospital. He was 85.
Scores of lung cancer experts from around the world gathered at the Miller School of Medicine April 16 for the 26th International Conference on Screening for Lung Cancer.
Show your support for Sylvester by contacting Governor Rick Scott at 850-488-7146 or firstname.lastname@example.org.
More than 3,200 walkers took part in the 12th Annual Pap Corps Walkathon at Florida Atlantic University in Boca Raton, enjoying one of the signature events of the all-volunteer group, which raises money exclusively for cancer research at Sylvester Comprehensive Cancer Center.
Stephen D. Nimer, M.D., one of the world’s premier leukemia and stem cell transplant researchers and clinicians, has been named the new director of the Sylvester Comprehensive Cancer Center.
A groundbreaking Miller School study funded by the National Cancer Institute’s Office of Cancer Survivorship has found all survivors of childhood cancer face a higher long-term risk of cardiovascular diseases and should be screened for a wide range of potential heart conditions.
As a Miller School researcher in her first faculty appointment, Erin Kobetz, Ph.D., M.P.H., discovered a high rate of cervical cancer among the women in Miami's Little Haiti neighborhood and teamed up with communiity collaborators to eradicate the preventable disease.
A new Miller School study has identified two cardiac biomarkers that could be early indicators of heart damage in childhood cancer survivors. The study, another major step in determining cardiac damage in childhood cancer patients, was led by Steven E. Lipshultz, M.D., professor and chair of pediatrics and executive associate dean for child health.
More than 200 researchers attended the Miller Office of Research's Shared Resources Fair on February 17, which was followed by a Collaborative Research Exchange Forum (CREF) on drug discovery.
The first patient in Florida to receive a novel vaccine for brain cancer, Cathy Hoffman-Booker is optimisitc about her participation in a clinical trial using a vaccine derived from her own brain tumor – a glioblastoma multiforme, the most common form of brain cancer.
Four UM researchers offered a glimpse of the exciting cancer research taking place at the Miller School at the 2012 Gastrointestinal Cancers Symposium, the largest meeting in the world dedicated to research and breakthroughs in gastrointestinal malignancies.
Accompanied by the Miller School's Joseph Rosenblatt, M.D., and Michael Lewis, MD., Dean Pascal J. Goldschmidt, M.D., joined Florida Governor Rick Scott last month on a trade mission to Israel aimed at attracting Israeli companies to Florida and fostering stronger ties between the Sunshine State and the Jewish state.
Former Miami Dolphins wide receiver Mark “Super” Duper had a rough ride during the second annual Dolphins Cycling Challenge on November 5, 2011. He never dreamed that as he was riding his bicycle to raise money for Sylvester Comprehensive Cancer Center in memory of Dolphins great Jim “Mad Dog” Mandich, there was a cancerous tumor growing inside his own body.
Thanks to a $2 million gift from businessman, philanthropist, and UM alumnus Alexander “Alex” Daly, UHealth-University of Miami Health System’s youngest cancer patients soon will receive outpatient care in a brand-new, state-of-the-art facility that caters to the unique needs of children.
Keyvan Nouri, M.D., the Richard Helfman Professor of Dermatologic Surgery, director of Mohs Micrographic Surgery, Dermatology, and Laser Surgery, and chief of Dermatology Services, Sylvester Comprehensive Cancer Center, accepted the first Louis C. Skinner, Jr., M.D., Endowed Chair in Dermatology at a January 18 ceremony on the Miller School campus.
A team of Miller School physician-scientists has demonstrated that an antagonist of growth hormone-releasing hormone (GHRH) has the ability to suppress the progression of late stage prostate cancer.